Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Lynch, Thomas L ^a   Sivaguru, Mayandi ^b   Velayutham, Murugesan ^c   Cardounel, Arturo J ^c   Michels, Michelle ^d   Barefield, David ^a   Govindan, Suresh ^a   Remedios, Cristobal Dos ^e   Van Der Velden, Jolanda ^f   Sadayappan, Sakthivel ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF SYDNEY   (Australia)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENCODING (SYMBOLS); HEART; IRON COMPOUNDS; MAMMALS; NONLINEAR OPTICS; OXIDATIVE STRESS; PARAMAGNETIC RESONANCE; PROTEINS;

BINDING PROTEINS; CONTRACTILE DYSFUNCTION; DILATED CARDIOMYOPATHY; ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY; HISTOPATHOLOGICAL ANALYSIS; OXIDATIVE STRESS MARKERS; PROTEIN CARBONYLS; SEMIQUINONE RADICALS;

C (PROGRAMMING LANGUAGE);

CARDIAC MYOSIN; CARDIAC MYOSIN BINDING PROTEIN C; GLUTATHIONE; MALONALDEHYDE; MYOSIN BINDING PROTEIN C; UNCLASSIFIED DRUG; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENERGY YIELD; FEMALE; GENE EXPRESSION; GENE MUTATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; M MODE ECHOCARDIOGRAPHY; MALE; MECHANICAL STRESS; MIDDLE AGED; MOUSE; NONHUMAN; OXIDATIVE STRESS; SARCOMERE; YOUNG ADULT; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; ECHOCARDIOGRAPHY; GENETICS; HEART; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION;

ADOLESCENT; ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; GLUTATHIONE; HEART; HUMANS; MALE; MALONDIALDEHYDE; MICE; MIDDLE AGED; MUTATION; MYOCARDIUM; OXIDATIVE STRESS; PROTEIN CARBONYLATION; YOUNG ADULT;

EID: 84945575176     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/424751     Document Type: Article

References (49)

1. A. S. Go, D. Mozaffarian, V. L. Roger, and et al, "Heart disease and stroke statistics-2014 update: a report from the American Heart Association," Circulation, vol. 129, no. 3, pp. e28-e292, 2014.
2. S. Morimoto, "Sarcomeric proteins and inherited cardiomyopathies," Cardiovascular Research, vol. 77, no. 4, pp. 659-666, 2008.
3. B. J. Maron and M. S. Maron, "Hypertrophic cardiomyopathy," The Lancet, vol. 381, no. 9862, pp. 242-255, 2013.
4. S. J. van Dijk, D. Dooijes, C. dos Remedios et al., "Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction," Circulation, vol. 119, no. 11, pp. 1473-1483, 2009.
5. S. Marston, O. Copeland, K. Gehmlich, S. Schlossarek, and L. Carrrier, "How do MYBPC3 mutations cause hypertrophic cardiomyopathy?" Journal of Muscle Research and Cell Motility, vol. 33, no. 1, pp. 75-80, 2012.
6. E. M. McNally, J. R. Golbus, and M. J. Puckelwartz, "Genetic mutations and mechanisms in dilated cardiomyopathy," Journal of Clinical Investigation, vol. 123, no. 1, pp. 19-26, 2013.
7. R. Lombardi, A. Bell, V. Senthil et al., "Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies," Cardiovascular Research, vol. 79, no. 1, pp. 109-117, 2008.
8. A. J. Marian, V. Senthil, S. N. Chen, and R. Lombardi, "Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation," Journal of the American College of Cardiology, vol. 47, no. 4, pp. 827-834, 2006.
9. R. Lombardi, G. Rodriguez, S. N. Chen et al., "Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitivemechanisms," Circulation, vol. 119, no. 10, pp. 1398-1407, 2009.
10. D. Lu, Y. Ma, W. Zhang et al., "Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnTR141W dilated cardiomyopathy transgenic mice," Hypertension, vol. 60, no. 1, pp. 81-89, 2012.
11. B. K. McConnell, K. A. Jones, D. Fatkin et al., "Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice," Journal of Clinical Investigation, vol. 104, no. 9, pp. 1235-1244, 1999.
12. D. Barefield, M. Kumar, P. P. de Tombe, and S. Sadayappan, "Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy," American Journal of Physiology-Heart and Circulatory Physiology, vol. 306, no. 6, pp. H807-H815, 2014.
13. B. K. McConnell, D. Fatkin, C. Semsarian et al., "Comparisonof two murine models of familial hypertrophic cardiomyopathy," Circulation Research, vol. 88, no. 4, pp. 383-389, 2001.
14. B.M. Palmer, D. Georgakopoulos, P. M. Janssen et al., "Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening," Circulation Research, vol. 94, no. 9, pp. 1249-1255, 2004.
15. J. B. Owen and D. A. Butterfield, "Measurement of oxidized/ reduced glutathione ratio.,"Methods inMolecular Biology, vol. 648, pp. 269-277, 2010.
16. O. Zitka, S. Skalickova, J. Gumulec et al., "Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients," Oncology Letters, vol. 4, no. 6, pp. 1247-1253, 2012.
17. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo, "Protein carbonyl groups as biomarkers of oxidative stress," Clinica Chimica Acta, vol. 329, no. 1-2, pp. 23-38, 2003.
18. S. Luo and N. B. Wehr, "Protein carbonylation: avoiding pitfalls in the 2, 4-dinitrophenylhydrazine assay," Redox Report, vol. 14, no. 4, pp. 159-166, 2009.
19. H. Esterbauer, R. J. Schaur, and H. Zollner, "Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes," Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81-128, 1991.
20. Y. Riahi, G. Cohen, O. Shamni, and S. Sasson, "Signaling and cytotoxic functions of 4-hydroxyalkenals," American Journal of Physiology-Endocrinology and Metabolism, vol. 299, no. 6, pp. E879-E886, 2010.
21. Y. Nishijima, A. Sridhar, I. Bonilla et al., "Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failureinduced alterations in atrial electrophysiology," Cardiovascular Research, vol. 91, no. 1, pp. 71-79, 2011.
22. S. I. Dikalov, I. A. Kirilyuk, M. Voinov, and I.A. Grigor'Ev, "EPR detection of cellular and mitochondrial superoxide using cyclic hydroxylamines," Free Radical Research, vol. 45, no. 4, pp. 417-430, 2011.
23. S. V. Plotnikov, A. C. Millard, P. J. Campagnola, and W. A. Mohler, "Characterization of the myosin-based source for second-harmonic generation from muscle sarcomeres," Biophysical Journal, vol. 90, no. 2, pp. 693-703, 2006.
24. M. Sivaguru, S. Durgam, R. Ambekar et al., "Quantitative analysis of collagen fiber organization in injured tendons using Fourier transform-second harmonic generation imaging," Optics Express, vol. 18, no. 24, pp. 24983-24993, 2010.
25. M. Sivaguru, J. P. Eichorst, S. Durgam, G. A. Fried, A. A. Stewart, andM.C. Stewart, "Imaging horse tendons usingmultimodal 2- photon microscopy," Methods, vol. 66, no. 2, pp. 256-267, 2014.
26. J. Schindelin, I. Arganda-Carreras, E. Frise et al., "Fiji: an opensource platformfor biological-image analysis," NatureMethods, vol. 9, no. 7, pp. 676-682, 2012.
27. P. P. Dimitrow, A. Undas, P. Wołkow, W. Tracz, and J. S. Dubiel, "Enhanced oxidative stress in hypertrophic cardiomyopathy," Pharmacological Reports, vol. 61, no. 3, pp. 491-495, 2009.
28. D. Romero-Alvira, E. Roche, and L. Placer, "Cardiomyopathies and oxidative stress," Medical Hypotheses, vol. 47, no. 2, pp. 137-144, 1996.
29. B. Halliwell, "Oxidative stress, nutrition and health. experimental strategies for optimization of nutritional antioxidant intake in humans," Free Radical Research, vol. 25, no. 1, pp. 57-74, 1996.
30. B. Halliwell and S. Chirico, "Lipid peroxidation: itsmechanism, measurement, and significance,"The American Journal of Clinical Nutrition, vol. 57, pp. 715S-725S, 1993.
31. M. Elas, J. Bielanska, K. Pustelny et al., "Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy," Free Radical Biology andMedicine, vol. 45, no. 3, pp. 321-328, 2008.
32. B. K. McConnell, K. A. Jones, D. Fatkin et al., "Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice," Journal of Clinical Investigation, vol. 104, article 1771, 1999.
33. S. V. Plotnikov, A. M. Kenny, S. J. Walsh et al., "Measurement of muscle disease by quantitative second-harmonic generation imaging," Journal of Biomedical Optics, vol. 13, no. 4, Article ID 044018, 2008.
34. D. Roude, G. Recher, J.-J. Bellanger, M.-T. Lavault, E. Schaub, and F. Tiaho, "Modeling of supramolecular centrosymmetry effect on sarcomeric SHG intensity pattern of skeletal muscles," Biophysical Journal, vol. 101, no. 2, pp. 494-503, 2011.
35. G. Recher, D. Rouede, E. Schaub, and F. Tiaho, "Skeletal muscle sarcomeric SHG patterns photo-conversion by femtosecond infrared laser," Biomedical Optics Express, vol. 2, no. 2, pp. 374-384, 2011.
36. R. S. Whelan, V. Kaplinskiy, and R. N. Kitsis, "Cell death in the pathogenesis of heart disease: mechanisms and significance," Annual Review of Physiology, vol. 72, pp. 19-44, 2009.
37. A. González, S. Ravassa, J. Beaumont, B. López, and J. Díez, "New targets to treat the structural remodeling of the myocardium," Journal of theAmericanCollege of Cardiology, vol. 58, no. 18, pp. 1833-1843, 2011.
38. D. Jarreta, J. Orús, A. Barrientos et al., "Mitochondrial function in heartmuscle frompatients with idiopathic dilated cardiomyopathy," Cardiovascular Research, vol. 45, no. 4, pp. 860-865, 2000.
39. M. R. Duchen, "Roles of mitochondria in health and disease," Diabetes, vol. 53, supplement 1, pp. S96-S102, 2004.
40. H. Tsutsui, S. Kinugawa, and S. Matsushima, "Oxidative stress and heart failure," American Journal of Physiology-Heart and Circulatory Physiology, vol. 301, no. 6, pp. H2181-H2190, 2011.
41. D. Yücel, S. Aydoʇdu, S. Çehreli et al., "Increased oxidative stress in dilated cardiomyopathic heart failure," Clinical Chemistry, vol. 44, no. 1, pp. 148-154, 1998.
42. D. J. Betteridge, "What is oxidative stress?" Metabolism, vol. 49, no. 2, pp. 3-8, 2000.
43. J. Nordberg and E. S. J. Arnér, "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system," Free Radical Biology andMedicine, vol. 31, no. 11, pp. 1287-1312, 2001.
44. Å. B. Gustafsson and R. A. Gottlieb, "Heart mitochondria: gates of life and death," Cardiovascular Research, vol. 77, no. 2, pp. 334-343, 2008.
45. G. Poli and M. Parola, "Oxidative damage and fibrogenesis," Free Radical Biology andMedicine, vol. 22, no. 1-2, pp. 287-305, 1997.
46. T. Ide, H. Tsutsui, S. Kinugawa et al., "Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium," Circulation Research, vol. 86, no. 2, pp. 152-157, 2000.
47. T. Ide, H. Tsutsui, S. Kinugawa et al., "Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium," Circulation Research, vol. 85, no. 4, pp. 357-363, 1999.
48. C. Chen and B. H. Paw, "Cellular and mitochondrial iron homeostasis in vertebrates," Biochimica et Biophysica Acta, vol. 1823, no. 9, pp. 1459-1467, 2012.
49. F. Foury and D. Talibi, "Mitochondrial control of iron homeostasis. A genome wide analysis of gene expression in a yeast frataxin-deficient strain," Journal of Biological Chemistry, vol. 276, no. 11, pp. 7762-7768, 2001.